Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2

Barbara C Godthelp1, Paul P W van Buul, Nicolaas G J Jaspers

  • 1Department of Toxicogenetics, Leiden University Medical Center, Building 2, Postzone S-6-P, 2300 RC, Leiden, The Netherlands.

Mutation Research
|August 22, 2006
PubMed
Summary

Fanconi anemia (FA) is a cancer disorder. Studying cells with BRCA2 mutations reveals they share traits with FA and homologous recombination (HR) deficient cells, impacting DNA repair pathways.

Related Concept Videos